Procurement Summary
Country : USA
Summary : Automated ID Serology Analyzer
Deadline : 16 Jul 2025
Other Information
Notice Type : Tender
TOT Ref.No.: 122334675
Document Ref. No. : PANHCA25P0000007866
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Description
Automated ID Serology Analyzer
SALIENT CHARACTERISTICS
General instrument characteristics include being able to run enzyme immunoassay (EIA) for infectious disease serology testing. Specifically, the instrument MUST be able to run the QuantiFERON TB Gold-Plus assay for detection of M. tuberculosis immune responses.
Characteristics:
Automated sample ID scanning and reagent ID scanning. Bar-coded data entry capabilities. Bi-directional interface for host connection to connect to LIS. Ability to receive approval for Authority to Operate (ATO) on Defense Health Agency (DHA) network within 1-year from start of contract and meet cyber security/network requirements. FDA-approved assays for: QuantiFERON TB Gold Plus Measles IgG Mumps IgG Rubella IgG VZV IgG Calprotecting Ag H. Pylori Ag Additional infectious disease serology assays may be added in the future to include: Rubella IgM CMV IgG/IgM Toxoplasma IgG/IgM HSV 1/2 IgG Preference will be given to platforms that have FDA-approved assays for the additional analytes specified. If a combined panel (e.g. MMRV, etc.) format is the only test format, must be able to do cost per reportable. System cannot require remote diagnostics for troubleshooting or required software updates. Random access or the ability run multiple assays at the same time with the ability to process at least 15, 000 specimens annually. Ready-to-use reagents, bar-coded cassettes. Must be able to provide system installation and set-up. Computer system (CPU, Monitor, Keyboard, Printer, ) with Custom Assay Protocol Files for Qiagen QuantiFERON TB Gold PLUS available, UPS for all instruments for the life of the instruments. Assay protocol files and results analysis/interpretation for other serology EIA/CLIA assays available through manufacturer or vendor for listed assays. Must be able to provide complete system validation (or assist facility with validation, as needed). Vendor will provide sufficient kits, at no cost to the...
Active Contract Opportunity
Notice ID : PANHCA25P0000007866
Related Notice
Department/Ind. Agency : DEPT OF DEFENSE
Sub-tier : DEPT OF THE ARMY
Major Command : US ARMY MEDICAL COMMAND
Office: W40M MRCO PACIFIC
General Information
Contract Opportunity Type: Sources Sought (Original)
Original Published Date: Jul 08, 2025 01:44 pm PDT
Original Response Date: Jul 16, 2025 02:00 pm PDT
Inactive Policy: 15 days after response date
Original Inactive Date: Jul 31, 2025
Initiative: None
Classification
Original Set Aside:
Product Service Code: 6550 - IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
NAICS Code: 325413 - In-Vitro Diagnostic Substance Manufacturing
Place of Performance: WA 98431 USA
Documents
Tender Notice